NicoxNICXF 37 Buyback Yield % is 0.00 as of Jul. 13, 2026. GuruFocus rates NICXF with a GF Score™ of 37/100 and a GF Value™ of $0.58. The stock has 2 warning signs investors should review. Among 742 Biotechnology companies, Nicox ranks worse than 134770.75% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Nicox's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NICXF vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, Nicox's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nicox Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nicox's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Nicox's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nicox (NICXF) has a Buyback Yield % of 0.00 as of Jul. 13, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Nicox and its competitors. According to the industry distribution chart, Nicox ranks #999999 out of 742 companies in the Biotechnology industry.
Is Nicox's Buyback Yield % too high?
Nicox's current Buyback Yield % is 0.00. Based on the distribution chart, Nicox ranks #999999 out of 742 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nicox has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Nicox's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nicox ranks #999999 out of 742 companies for Buyback Yield %. This places Nicox in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Nicox and its competitors. Nicox's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nicox stock overvalued right now?
Nicox (NICXF) has a current Buyback Yield % of 0.00. The stock's GF Value™ is $0.58, compared to a current price of $0.30 — trading 48.3% below its estimated fair value. The current Buyback Yield % is 0.00. Nicox's overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Nicox (NICXF), the current Buyback Yield % is 0.00 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nicox (NICXF) Overvalued in 2026?
Based on GuruFocus' analysis, Nicox stock appears to be undervalued.
The current stock price of $0.30 is trading 48.3% below its estimated GF Value™ of $0.58.
Key valuation signals for NICXF:
Buyback Yield %: 0.00
GF Value™: $0.58 vs. price of $0.30 (48.3% below fair value)
No single metric tells the full story. See the NICXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nicox SA is an international ophthalmology company developing solutions to help preserve vision and improve ocular health. It is developing a portfolio of treatments targeting glaucoma, diseases of the anterior segment and retinal diseases. A drug candidate (NCX 470) in phase 3 clinical development designed to reduce intraocular pressure ("IOP") in patients with open-angle glaucoma or ocular hypertension. A drug candidate (NCX 1728) in preclinical development for retinal diseases and glaucoma, derived from Nicox's proprietary nitric oxide (NO)-donating research platform. Its products are ZERVIATE, VYZULTA, Naproxcinod, etc.
37GF Score
Get the complete analysis for NICXF
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NICXF has been successfully added to your 
